Gossamer Bio GOSS
NASDAQ GOSS
$10.11 +0.53 (+5.58%)
As of: Oct 21, 2026 · 11:39 AM EDT

Gossamer Bio (GOSS) Share-based Compensation (2018 - 2026)

Updated

Gossamer Bio (GOSS) posted Share-based Compensation of $2.46 million for Q2 2026, down 4.8% from $2.59 million a year earlier and down 60.9% from the prior quarter.

Analysis

Gossamer Bio (GOSS) Share-based Compensation (2018 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Share-based Compensation at Gossamer Bio was $14.33 million, down 3.2% year-over-year; for FY2025, it came in at $10.56 million, down 48.8% from FY2024.

  • Annual Share-based Compensation has declined for three consecutive years, with a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
  • In prior years, Gossamer Bio's Share-based Compensation was $20.62 million in FY2024 (-27.7%), $28.52 million in FY2023 (-33.0%), $42.55 million in FY2022 (+32.9%) and $32.01 million in FY2021 (-17.4%).
  • The Q2 2026 figure stands as the lowest quarterly Share-based Compensation since Q1 2025.
  • On a year-over-year basis, Share-based Compensation increased in 1 of the last eight quarters, with an average decline of 9.4%.
  • The strongest year-over-year quarter for Share-based Compensation in the past five years was Q1 2026, with growth of 162.1%; the weakest was Q1 2025, with a decline of 58.6%.
  • According to Business Quant data, Share-based Compensation for the three prior quarters was $6.3 million (Q1 2026), $2.9 million (Q4 2025) and $2.67 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Eli Lilly 1,130.22 Bn 1,098.81 Bn 19.71 Bn 201.00 Mn
2 Johnson & Johnson 613.62 Bn 532.15 Bn 17.26 Bn 458.00 Mn
3 AbbVie 501.46 Bn 474.57 Bn 12.70 Bn 166.00 Mn
4 Merck 366.84 Bn 321.22 Bn 12.21 Bn 298.00 Mn
5 Novartis Ag 297.85 Bn 261.84 Bn 11.24 Bn -
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn -
7 Amgen 235.39 Bn 190.79 Bn 7.24 Bn 165.00 Mn
8 Gilead Sciences 190.66 Bn 164.86 Bn 6.22 Bn 231.00 Mn
9 Pfizer 169.57 Bn 116.22 Bn 10.94 Bn 249.00 Mn
10 Gossamer Bio 40.40 Mn -433.00 Mn - 2.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.46 Mn
Mar 31, 2026 6.30 Mn
Dec 31, 2025 2.90 Mn
Sep 30, 2025 2.67 Mn
Jun 30, 2025 2.59 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 4.97 Mn
Sep 30, 2024 4.84 Mn
Jun 30, 2024 5.00 Mn
Mar 31, 2024 5.81 Mn
Dec 31, 2023 6.03 Mn
Sep 30, 2023 6.16 Mn
Jun 30, 2023 8.20 Mn
Mar 31, 2023 8.13 Mn
Dec 31, 2022 11.45 Mn
Sep 30, 2022 10.12 Mn
Jun 30, 2022 10.00 Mn
Mar 31, 2022 10.98 Mn
Dec 31, 2021 7.66 Mn
Sep 30, 2021 7.59 Mn
API Access

Gossamer Bio Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=GOSS&period=max&api_key=YOUR_API_KEY